North Shore Geriatric Care Management

09/18/2025

Looking forward to this Sunday the 21st- the walk to END ALZ💜. If you would like to walk with us or donate to this amazing organization, please click the link below for more walk details, registration and donation link. Thanks for your support as always!

I am participating in Walk to End Alzheimer's. Donate today and help me reach my goal.

05/23/2025

Good news💜🙏🏻

The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and treat the disease.

08/08/2024

Grateful for your ongoing support as I walk again this year for this wonderful organization and important cause 💜🙏🏻. Would be honored to have you walk on our team!

Please consider joining our team, donating… every dollar counts, and making a difference in the fight to END Alzheimer’s disease and other dementias .

I am participating in Walk to End Alzheimer's. Donate today and help me reach my goal.

07/29/2024

Incredibly promising blood test on the horizon 🙏🏻

Blood tests that can detect 90% of Alzheimer’s cases could revolutionize access to Alzheimer’s treatment, studies say.

07/02/2024

Promising news 💜🙏🏻

The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.

02/10/2024

Received a beautiful article and note today from a former client’s son. (I wanted to share this with you, as you helped make his (and my mom’s) last days the best they could be… Thank you so much for reading and for all you did for my parents!). ❤️🙏🏻

"After three weeks visiting my dad, I was scheduled to fly home. 'I don’t want you to go,' he told me."

07/17/2023

Today’s full study results for the Alzheimer’s treatment donanemab bring more hope for those living with early Alzheimer’s. Nearly half of study participants at the earliest stage of disease who received the drug had no decline at one year.

“These benefits are real and meaningful,” says Maria C. Carrillo, Ph.D, our chief science officer “With this fuller picture, there is additional, convincing scientific evidence that thoroughly removing beta amyloid from the brain is associated with significant slowing of disease progression in people living with early Alzheimer’s.”

The drug appeared to more effective than the recently approved drug Leqembi, but it may also come with higher rates of dangerous side effects.

06/30/2023

As a Gerontologist, I support and advocate for the caregiver and family member/s, just as much as the patient themselves. “Caring for the caregiver” is critical, especially when supporting loved ones with Dementia… a diagnosis that can last for decades. It has been an honor & privilege to help families on their caregiving journey over the last three decades. Quoted in an article below… Thank you Chicago Caregiving Magazine💜🙏🏻.

By Lorna CollierLorna Collier is a health and education writer whose articles have appeared in the Chicago Tribune, Next Avenue, USNews.com and many others. www.lornacollier.comTake your turn in our first-ever caregiving game, and learn everything you need for each step of the way Your child has a d...

03/19/2023

An estimated 18 million middle-income baby boomers will not have enough to pay for care for moderate to severe needs, according to one analysis.

12/11/2022

After decades in the shadow of the reigning model for Alzheimer’s disease, alternative explanations are finally getting the attention they deserve.

12/05/2021

Simple activities like walking boost immune cells in the brain that may help to keep memory sharp and even ward off Alzheimer’s disease.

06/15/2021

The first Alzheimer’s disease FDA medication approval since 2003... it has doctor’s phones ringing off the hook... is this the magic pill they had hoped for?

"Everybody is looking for a drug that actually modifies the progression" of Alzheimer's, geriatrician Sharon Brangman said. “And we don't have enough data to know if this is that drug.”